Literature DB >> 13435388

Vaccination against acute respiratory illness of adenovirus (RI-APC-ARD) etiology.

M R HILLEMAN, R A STALLONES, R L GAULD, M S WARFIELD, S A ANDERSON.   

Abstract

Entities:  

Keywords:  VIRUS DISEASES/prevention and control

Mesh：

Year:  1957        PMID： 13435388      PMCID： PMC1551197          DOI： 10.2105/ajph.47.7.841

Source DB:  PubMed          Journal:  Am J Public Health Nations Health        ISSN： 0002-9572


× No keyword cloud information.
  17 in total

1.  Etiologic relationship of the RI-67 agent to acute respiratory disease (ARD).

Authors:  H S GINSBERG; G F BADGER; J H DINGLE; W S JORDAN; S KATZ
Journal:  J Clin Invest       Date:  1955-06       Impact factor: 14.808

2.  new type of APC virus from epidemic keratoconjunctivitis.

Authors:  E JAWETZ; S KIMURA; A N NICHOLAS; P THYGESON; L HANNA
Journal:  Science       Date:  1955-12-16       Impact factor: 47.728

3.  Efficacy of trivalent adenovirus (APC) vaccine in naval recruits.

Authors:  J A BELL; M J HANTOVER; R J HEUNER; C G LOOSLI
Journal:  J Am Med Assoc       Date:  1956-08-18

4.  Etiology of acute respiratory disease among service personnel at Fort Ord, California.

Authors:  T O BERGE; B ENGLAND; C MAURIS; H E SHUEY; E H LENNETTE
Journal:  Am J Hyg       Date:  1955-11

5.  Prevention of acute respiratory illness in recruits by adenovirus (RI-APC-ARD) vaccine.

Authors:  M R HILLEMAN; R A STALLONES; R L GAULD; M S WARFIELD; S A ANDERSON
Journal:  Proc Soc Exp Biol Med       Date:  1956-06

6.  Adenoviruses: group name proposed for new respiratory-tract viruses.

Authors:  J F ENDERS; J A BELL; J H DINGLE; T FRANCIS; M R HILLEMAN; R J HUEBNER; A M PAYNE
Journal:  Science       Date:  1956-07-20       Impact factor: 47.728

7.  Biophysical characterization of the RI (RI-67) viruses.

Authors:  M R HILLEMAN; A J TOUSIMIS; J H WERNER
Journal:  Proc Soc Exp Biol Med       Date:  1955-08

8.  Grouping and occurrence of RI (prototype RI-67) viruses.

Authors:  M R HILLEMAN; J H WERNER; M T STEWART
Journal:  Proc Soc Exp Biol Med       Date:  1955-12

9.  Adenoidal-pharyngeal-conjunctival agents: a newly recognized group of common viruses of the respiratory system.

Authors:  R J HUEBNER; W P ROWE; T G WARD; R H PARROTT; J A BELL
Journal:  N Engl J Med       Date:  1954-12-30       Impact factor: 91.245

10.  Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture.

Authors:  W P ROWE; R J HUEBNER; L K GILMORE; R H PARROTT; T G WARD
Journal:  Proc Soc Exp Biol Med       Date:  1953-12
View more
  6 in total

1.  Viruses of diseases of the respiratory tract.

Authors:  C H STUART-HARRIS
Journal:  Br Med J       Date:  1962-10-06

2.  Broad spectrum respiratory pathogen analysis of throat swabs from military recruits reveals interference between rhinoviruses and adenoviruses.

Authors:  Zheng Wang; Anthony P Malanoski; Baochuan Lin; Nina C Long; Tomasz A Leski; Kate M Blaney; Christian J Hansen; Jason Brown; Michael Broderick; David A Stenger; Clark Tibbetts; Kevin L Russell; David Metzgar
Journal:  Microb Ecol       Date:  2010-03-09       Impact factor: 4.552

3.  Applying genomic and bioinformatic resources to human adenovirus genomes for use in vaccine development and for applications in vector development for gene delivery.

Authors:  Jason Seto; Michael P Walsh; Padmanabhan Mahadevan; Qiwei Zhang; Donald Seto
Journal:  Viruses       Date:  2010-01-06       Impact factor: 5.818

4.  Live Oral Adenovirus Type 4 and Type 7 Vaccine Induces Durable Antibody Response.

Authors:  Natalie D Collins; Anima Adhikari; Yu Yang; Robert A Kuschner; Nicos Karasavvas; Leonard N Binn; Shannon D Walls; Paul C F Graf; Christopher A Myers; Richard G Jarman; Jun Hang
Journal:  Vaccines (Basel)       Date:  2020-07-23

5.  Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques.

Authors:  Jingyou Yu; Natalie D Collins; Noe B Mercado; Katherine McMahan; Abishek Chandrashekar; Jinyan Liu; Tochi Anioke; Aiquan Chang; Victoria M Giffin; David L Hope; Daniel Sellers; Felix Nampanya; Sarah Gardner; Julia Barrett; Huahua Wan; Jason Velasco; Elyse Teow; Anthony Cook; Alex Van Ry; Laurent Pessaint; Hanne Andersen; Mark G Lewis; Christian Hofer; Donald S Burke; Erica K Barkei; Hannah A D King; Caroline Subra; Diane Bolton; Kayvon Modjarrad; Nelson L Michael; Dan H Barouch
Journal:  J Virol       Date:  2021-10-27       Impact factor: 5.103

Review 6.  Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence.

Authors:  Daniele Focosi; Fabrizio Maggi; Arturo Casadevall
Journal:  Viruses       Date:  2022-01-19       Impact factor: 5.048
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.